MENU
+Compare
MREO
Stock ticker: NASDAQ
AS OF
Apr 23, 04:59 PM (EDT)
Price
$2.56
Change
+$0.06 (+2.40%)
Capitalization
397.5M

MREO Mereo BioPharma Group plc Forecast, Technical & Fundamental Analysis

Mereo BioPharma Group PLC is a United Kingdom (U... Show more

MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MREO with price predictions
Apr 22, 2025

MREO's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for MREO moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on MREO as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MREO just turned positive on April 16, 2025. Looking at past instances where MREO's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

MREO moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MREO advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

MREO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MREO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MREO entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MREO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.519) is normal, around the industry mean (13.887). P/E Ratio (0.000) is within average values for comparable stocks, (63.180). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (344.828) is also within normal values, averaging (251.479).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MREO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MREO is expected to report earnings to fall 240.00% to 1 cents per share on May 14

Mereo BioPharma Group plc MREO Stock Earnings Reports
Q1'25
Est.
$0.01
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.02
Q2'24
Missed
by $0.01
Q4'23
Est.
$-0.02
The last earnings report on March 26 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 2.61M shares outstanding, the current market capitalization sits at 397.50M.
A.I. Advisor
published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGCX41.280.92
+2.28%
Janus Henderson Glb Tech and Innovt C
JIGZX65.21N/A
N/A
JPMorgan U.S. GARP Equity R2
KTRCX8.37N/A
N/A
DWS Global Income Builder C
CLTIX13.87N/A
N/A
Catalyst/Lyons Tactical Allocation I
MOWNX16.55N/A
N/A
Moerus Worldwide Value N

MREO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with VKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+7.30%
VKTX - MREO
43%
Loosely correlated
+7.42%
TRDA - MREO
42%
Loosely correlated
+9.56%
CRNX - MREO
42%
Loosely correlated
+3.71%
TERN - MREO
41%
Loosely correlated
+3.32%
ACLX - MREO
40%
Loosely correlated
+3.59%
More